AQR Arbitrage’s Lux Health Tech Acquisition Corp. Class A Common Stock LUXA Stock Holding History

AQR Arbitrage’s Portfolio LUXA Stock Details LUXA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-676,137	Closed	-$6.77M	–	1521
2022 Q3	$6.77M	Hold	676,137	–	–	0.15%	181
2022 Q2	$6.69M	Buy	676,137 +349,309	+107%	+$3.45M	0.15%	189
2022 Q1	$3.22M	Buy	326,828 +314,120	+2,472%	+$3.09M	0.08%	274
2021 Q4	$125K	Hold	12,708	–	–	﹤0.01%	1175
2021 Q3	$125K	Sell	12,708 -53,290	-81%	-$525K	﹤0.01%	784
2021 Q2	$653K	Hold	65,998	–	–	0.02%	570
2021 Q1	$678K	Buy	+65,998	New	+$733K	0.02%	498

AQR Arbitrage's LUXA Position: Q4 2022 in Review

AQR Arbitrage sold out of Lux Health Tech Acquisition Corp. Class A Common Stock (LUXA) in Q4 2022, closing a stake of 676,137 shares — an estimated $6.77M sold.

AQR Arbitrage first reported a position in LUXA in Q1 2021 and held it in 7 quarters. The position peaked at $6.77M in Q3 2022. 0 funds tracked by Wall St. Rank hold LUXA as of Q4 2022.

AQR Arbitrage reported no remaining Lux Health Tech Acquisition Corp. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
AQR Arbitrage sold 676,137 Lux Health Tech Acquisition Corp. Class A Common Stock shares in Q4 2022, an estimated $6.77M.
AQR Arbitrage first reported a position in Lux Health Tech Acquisition Corp. Class A Common Stock in Q1 2021 and held it in 7 quarters.
AQR Arbitrage's Lux Health Tech Acquisition Corp. Class A Common Stock position peaked at $6.77M in Q3 2022.
0 funds tracked by Wall St. Rank held Lux Health Tech Acquisition Corp. Class A Common Stock as of Q4 2022.

Based on AQR Arbitrage's 13F filing for Q4 2022, filed 14 Feb 2023.